Navigation Links
Restorative Therapies, Inc., Today Announced a Rehabilitation Breakthrough, the RT600 Functional Electrical Stimulation (FES) Stepper
Date:5/31/2011

BALTIMORE, May 31, 2011 /PRNewswire/ -- Restorative Therapies, Inc., advances its new era in physical therapy systems for neurological injury and paralysis with FDA clearance of the world's first Functional Electrical Stimulation (FES) rehabilitation therapy system for stepping and standing.

FES is a physical therapy rehabilitation modality used to evoke physical activity and exercise not otherwise possible for individuals with a neurological impairment such as a spinal cord injury, stroke, multiple sclerosis or cerebral palsy.  The new RT600 system delivers electrical currents to stimulate nerves which activate core and leg muscles including the quadriceps, hamstrings, gluteals, gastroc, anterior tibialis, abdominals and erector spinae to evoke stepping and standing activity.  This rehabilitation enables a patient's paralyzed or weak legs to move through patterned physical activity utilizing their own muscles while safely positioned in a partial body weight supporting harness.

"The RT600 is the first physical therapy system to bring the established benefits of FES to weight supported stepping for people with neurological impairments," said Prof. David Ditor of Brock University, in Ontario, Canada.

"It is the first truly practical rehabilitation system of this kind that I have seen.  In addition to combining several valuable neuro-rehabilitation interventions, functional electrical stimulation, locomotor gait training and neuromuscular re-education, the RT600 is small and easy enough to use that I can one day envision it in the patient's home," said Cristina Sadowsky of the Kennedy Krieger Institute in Baltimore, Maryland.

"In the context of rehabilitation influencing neural plasticity
'/>"/>

SOURCE Restorative Therapies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Angiomax Will Retain Decision Resources Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI
2. Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkins Lymphoma
3. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
4. Fredericksburg Nephrology Associates, Inc., Successfully Attests to Meaningful Use Using Acumen EHR
5. Repro-Med Systems, Inc., Reports 30% Increase in Revenue for Fiscal Year Ended February 28, 2011
6. Newtech, Inc., a Leading Chinese EMS Patient Monitoring Company, Partners With Masimo to Incorporate rainbow® SET Noninvasive Measurement Capabilities Into New Patient Monitors
7. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
8. Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP
9. Verathon Inc., Maker of BladderScan and GlideScope Medical Instruments, Partners With IVUmed to Sponsor Traveling Resident Scholars
10. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
11. NovaSperse(SM) Nanoparticle Innovator, PharmaNova, Inc., Awarded Four Government Grants Toward Development of New Therapeutic Products Under Congressional Qualifying Therapeutic Discovery Project Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... , , FRANKLIN LAKES, N.J., Jan. 11 ... announced today that it will conduct a live webcast of its ... 2010 at 10:00 a.m. (ET). BD will issue a press ... of the conference call, along with related slides, will be accessible ...
... Calif., Jan. 11 Finesse Solutions, LLC, a manufacturer ... applications, announced the production release of its single-use sensor ... and process temperature, and TruTorr headspace pressure sensors. ... ease of use. It is available on the Thermo ...
Cached Medicine Technology:BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call 2Single-Use Sensor Product Family Enters High Volume Production 2
(Date:4/18/2014)... turns 160 years of neuroanatomy on its head. , ... essential for the fast transmission of impulses along the ... thought, according to a new work lead by Professor ... and the University,s Department of Stem Cell and Regenerative ... Department of Molecular and Cellular Biology. , "Myelin is ...
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/17/2014)... in benign prostate tissue was associated with high-grade, ... found even in those with low prostate-specific antigen ... Cancer Epidemiology, Biomarkers & Prevention , a ... , An analysis of prostate tissue biopsies collected ... the Prostate Cancer Prevention Trial (PCPT) found that ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2
... it has received marketing authorization from the European Commission ... treatment for severe Crohn's disease. HUMIRA is the first ... offers an effective and convenient treatment option that can ... This announcement follows FDA approval for the Crohn's disease ...
... the figures suggests that India really has between two and ... of last year. The survey was carried out under ... for India would imply that India has managed to keep ... that the virus circulates mostly within high-risk groups. In Indias ...
... of health care via health scare in the West. Panic ... efforts on a vast scale. In Canada after the ... is engaging the attention of the Ontario province authorities. ... to flush their water pipes daily. Provocation? Water samples ...
... Following reports of irruption of legionnaires outbreak in Melbourne, ... are being scoured to locate the source ... and confirmed to be suffering from the legionnaires. ... pneumonia and it is caused by the bacterium ...
... made to stop the spread of TB as about,420,000 of ... the,world were resistant to many standard anti-tuberculosis drugs, said a,WHO ... TB in 2004 is found,to show more resistant to drugs ... Dr Paul P Nunn, a TB expert with WHO.,``It may ...
... Medical drugs Center researchers have opened up a new way ... develop new drugs. ,The Duke researches compared ... human cells and rats. The drugs in question were the ... newer drug lapatinib, whose trade name is Tykerb. ...
Cached Medicine News:Health News:Abbott's Humira(r) (Adalimumab) Gets Approval by EU for Crohn's Disease Treatment 2Health News:AIDS Incidence in India Far Lower Than Previously Estimated New Study 2Health News:AIDS Incidence in India Far Lower Than Previously Estimated New Study 3Health News:Flush Water Pipes to Reduce Lead Contamination Risk, Schools Told 2Health News:Flush Water Pipes to Reduce Lead Contamination Risk, Schools Told 3Health News:Legionnaires Outbreak in Australia 2Health News:WHO Cautions Against Spread of Drug-resistant Tuberculosis. 2Health News:Breast Cancer Drug Curbs Heart Disease. 2Health News:Breast Cancer Drug Curbs Heart Disease. 3
... on/off switch which allows user to stop rotor ... hinge, with stainless steel pin is virtually indestructible. ... Spins 6 microcentrifuge tubes at low to medium ... g. 6 inch x 6 inch footprint. Starts ...
Inquire...
Spectrafuge 16M High speed microcentrifuge. High g-force for molecular biology applications. Brushless, maintenance-free motor. Easy to use control panel. Complete with 18 x 1.5/2.0 ml rotor. StripSp...
... Powerful single rotation speed of 10,000 ... (x g) , Pellets single- and double-stranded ... and continuous spinning , 12-position rotor holds ... 1.5-ml microcentrifuge tubes , Replaceable rotor ...
Medicine Products: